Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (SHA:603392)

Market Cap	69.20B
Revenue (ttm)	1.72B
Net Income (ttm)	-298.28M
Shares Out	1.27B
EPS (ttm)	-0.22
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,967,635
Average Volume	2,895,168
Open	55.09
Previous Close	55.05
Day's Range	54.63 - 55.29
52-Week Range	54.24 - 80.00
Beta	1.21
RSI	37.45
Earnings Date	Oct 30, 2025

About SHA:603392

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. research, develops, produces, distributes, and sells vitro diagnostic reagents and vaccines in China and internationally. The company provides chemiluminescence series, assembly line series, nucleic acid series, dry type fluorescent immunoassay, and fully automatic blood type analyzer and reagents; ELISA kits; rapid diagnosis; bole series; and supporting reagents. It also provides HPV, hepatitis E, and nasal spray COVID-19 vaccine. In addition, the company offers bio-immune and immunoassay...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1991
• Employees: 3,790
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 603392

Financial Performance

In 2024, SHA:603392's revenue was 2.25 billion, a decrease of -59.25% compared to the previous year's 5.51 billion. Earnings were 106.24 million, a decrease of -91.49%.